US biotech Mustang Bio says that an investigator-led trial of its CAR-T therapy for multiple myeloma – the first to target CS1 protein – has started recruiting patients. The multiple myeloma pipeline ...
China’s CAR T market is expected to grow from $72 million in 2022 to $342 million over the next decade. There are currently more than 400 CAR T therapies in the pipeline in China, and most of these ...
Not every Belgian beer style has survived the march of time. Some have disappeared as casualties of war, regulation, or changing work patterns; others have succumbed to industrial pressures or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback